Tacrolimus (Graceptor (R)) for GVHD prophylaxis after allogeneic stem cell transplantation.
Phase of Trial: Phase II
Latest Information Update: 11 May 2015
At a glance
- Drugs Tacrolimus (Primary)
- Indications Graft-versus-host disease
- Focus Pharmacokinetics
- 08 May 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 06 Oct 2009 New trial record